[Melfalan in the treatment of proliferative vitreoretinopathy (experimental study)].

I P Khoroshilova-Maslova N L Leparskaya Elena V Alpeeva Ekaterina A Vorotelyak

Published in: Vestnik oftalmologii (2020)

A single intravitreal injection of 0.005 mg Melphalan had a positive therapeutic antiproliferative effect on the PVR model with minimal retinotoxic changes.

Keyphrases

vascular endothelial growth factor
diabetic retinopathy
ultrasound guided
combination therapy
low dose